Al-Dawaa Medical Services Company (4163.SR) — Financial statements
Income statement, balance sheet, and cash flow for Al-Dawaa Medical Services Company — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6,736↑4.4% | 6,451↑12.4% | 5,741↑6.9% | 5,372↑6.7% | 5,034 | |
| Cost of Revenue | 4,363↑4.9% | 4,158↑13.1% | 3,677↑9.7% | 3,353↑6.8% | 3,140 | |
| Gross Profit | 2,373↑3.5% | 2,293↑11.1% | 2,065↑2.2% | 2,020↑6.6% | 1,894 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 44↑5.3% | 41↓20.8% | 52↑1.3% | 52 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 219↑6.6% | 206↓2.9% | 212↑2.0% | 208 | |
| SG&A Expenses | 0.00↓100.0% | 263↑6.4% | 247↓6.4% | 264↑1.8% | 259 | |
| Other Expenses | 1,905↑25.6% | 1,516↑22434.2% | 7↑1113.8% | -0.66↑91.8% | -8 | |
| Operating Expenses | 1,905↑7.1% | 1,779↑11.3% | 1,598↓2.9% | 1,645↑1.5% | 1,621 | |
| Total Costs & Expenses | 6,268↑5.6% | 5,937↑12.6% | 5,275↑5.5% | 4,998↑5.0% | 4,761 | |
| Operating Results | ||||||
| Operating Income | 464↓9.7% | 514↑10.2% | 467↑26.5% | 369↑37.8% | 268 | |
| Depreciation & Amortization | 417↑8.9% | 383↑5.2% | 364↑2.6% | 355↑6.2% | 334 | |
| EBITDA | 881↓1.8% | 897↑8.0% | 830↑5.9% | 784↑18.3% | 663 | |
| EBIT | 464↓9.7% | 514↑10.2% | 467↑7.3% | 435↑32.3% | 329 | |
| Interest & Other Income | ||||||
| Net Interest Income | -114↑20.0% | -143↓14.9% | -124↓6.2% | -117↓41.4% | -83 | |
| Interest Income | 0.00↑100.0% | -21 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 114↓6.3% | 122↓2.0% | 124↑6.2% | 117↑41.4% | 83 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↑100.0% | -59↑2.7% | -61 | |
| Other Income / Expenses | -132↓8.6% | -122↑2.0% | -124↓115.2% | -58↓164.0% | -22 | |
| Income Before Tax | 332↓15.4% | 392↑14.6% | 342↑7.7% | 318↑29.2% | 246 | |
| Income Tax Expense | 10↓54.5% | 22↑68.0% | 13↑6.1% | 12↑80.7% | 7 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 322↓13.1% | 370↑12.4% | 329↑7.8% | 305↑27.7% | 239 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 322↓13.1% | 370↑12.4% | 329↑7.8% | 305↑27.7% | 239 | |
| Bottom-Line Net Income | 322↓13.1% | 370↑12.4% | 329↑7.8% | 305↑27.7% | 239 | |
| EPS (Basic) | 3.79↓12.9% | 4.35↑12.4% | 3.87↑7.8% | 3.59↑27.8% | 2.81 | |
| EPS (Diluted) | 3.79↓12.9% | 4.35↑12.4% | 3.87↑7.8% | 3.59↑27.8% | 2.81 | |
| Weighted Average Shares | 85↓0.1% | 85↑0.0% | 85↑0.0% | 85↑0.0% | 85 | |
| Weighted Average Diluted Shares | 85↓0.1% | 85↑0.0% | 85↑0.0% | 85↑0.0% | 85 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.